IOL Chemicals and Pharmaceuticals share news, announcements and annual reports
NSE: IOLCPBSE: 524164Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹184.93.
30 Oct: open ₹186.40, high ₹186.40, low ₹176.02
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,215 Cr1,024th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 25.66
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.71
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.56%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 18,08,91234.0% delivered
IOL Chemicals and Pharmaceuticals routine notices
308 filed, newest first. Page 5 of 7.
Aug 2021
25 Aug · Routine
16 Aug · Routine
5 Aug · Routine
4 Aug · Routine
Jul 2021
30 Jul · Routine
29 Jul · Routine
19 Jul · Routine
19 Jul · Routine
17 Jul · Routine
Jun 2021
24 Jun · Routine
24 Jun · Routine
23 Jun · Routine
7 Jun · Routine
3 Jun · Routine
1 Jun · Routine
1 Jun · Routine
May 2021
31 May · Routine
31 May · Routine
18 May · Routine
Apr 2021
14 Apr · Routine
12 Apr · Routine
12 Apr · Routine
Mar 2021
25 Mar · Routine
24 Mar · Routine
15 Mar · Routine
13 Mar · Routine
9 Mar · Routine
Feb 2021
28 Feb · Routine
26 Feb · Routine
20 Feb · Routine
19 Feb · Routine
16 Feb · Routine
12 Feb · Routine
11 Feb · Routine
11 Feb · Routine
3 Feb · Routine
Jan 2021
23 Jan · Routine
22 Jan · Routine
22 Jan · Routine
19 Jan · Routine
18 Jan · Routine
4 Jan · Routine
2 Jan · Routine
Dec 2020